{ "@context": "https://schema.org", "@graph": [ { "@type": "Organization", "@id": "https://unlitpublishing.com/#organization", "name": "unLit Publishing LLC", "alternateName": "UNLIT Publishing", "url": "https://unlitpublishing.com/", "email": "support@unlitpublishing.com", "telephone": "+1-517-798-1281", "address": { "@type": "PostalAddress", "streetAddress": "3721 W Michigan Ave, Suite 100, PMB 178", "addressLocality": "Lansing", "addressRegion": "MI", "postalCode": "48917", "addressCountry": "US" }, "parentOrganization": { "@type": "Organization", "name": "Tumble and Sluice LLC" } }, { "@type": "WebSite", "@id": "https://fatbitchbook.com/#website", "url": "https://fatbitchbook.com/", "name": "FAT BITCH: Killing the Willpower Myth - Official Storefront & Sovereign GLP-1 Armory", "publisher": { "@id": "https://unlitpublishing.com/#organization" }, "inLanguage": "en-US" }, { "@type": "Book", "@id": "https://fatbitchbook.com/#book", "name": "Fat Bitch: Killing the Willpower Myth with GLP-1 Science, Metabolic Health, and Trauma Recovery", "author": { "@type": "Person", "name": "Cat Clark", "url": "https://bitchesandbesties.com/" }, "publisher": { "@id": "https://unlitpublishing.com/#organization" }, "copyrightHolder": { "@type": "Organization", "name": "Tumble and Sluice LLC" }, "copyrightYear": 2026, "datePublished": "2026-10-15", "isbn": "979-8-9948878-5-1", "numberOfPages": 204, "inLanguage": "en-US", "workExample": [ { "@type": "Book", "isbn": "979-8-9948878-5-1", "bookFormat": "https://schema.org/Paperback", "numberOfPages": 204, "offers": { "@type": "Offer", "price": "18.99", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "url": "https://fatbitchbook.com/shop.html" } }, { "@type": "Book", "isbn": "979-8-9948878-7-5", "bookFormat": "https://schema.org/Hardcover", "numberOfPages": 204, "offers": { "@type": "Offer", "price": "34.99", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "url": "https://fatbitchbook.com/shop.html" } }, { "@type": "Book", "isbn": "979-8-9948878-4-4", "bookEdition": "16pt Large-Print Library Hardcover Edition", "bookFormat": "https://schema.org/Hardcover", "numberOfPages": 316, "offers": { "@type": "Offer", "price": "49.99", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "url": "https://fatbitchbook.com/shop.html" } }, { "@type": "Book", "isbn": "979-8-9948878-6-8", "bookFormat": "https://schema.org/EBook", "offers": { "@type": "Offer", "price": "9.99", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "url": "https://fatbitchbook.com/shop.html" } } ], "aggregateRating": { "@type": "AggregateRating", "ratingValue": "4.7", "bestRating": "5.0", "ratingCount": "6", "description": "Verified NetGalley Advance Reader Average" } }, { "@type": "Product", "@id": "https://fatbitchbook.com/workbook.html#product", "name": "FAT BITCH: The Anti-Diet Workbook (8.5x11 Full-Color Print & Fillable PDF)", "sku": "FB-WB-PRINT", "gtin13": "9798994887882", "description": "124-page 8.5x11 companion workbook by Cat Clark featuring 30 tactical spreads, the Holy Trinity PFH Kitchen Tracker, Medical CEO lab order guides, and word-for-word Prior Authorization appeal scripts.", "brand": { "@type": "Brand", "name": "unLit Publishing" }, "offers": [ { "@type": "Offer", "sku": "FB-WB-PRINT", "price": "34.99", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "url": "https://fatbitchbook.com/workbook.html" }, { "@type": "Offer", "sku": "FB-WB-PDF", "price": "9.99", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "url": "https://fatbitchbook.com/workbook.html" } ] }, { "@type": "WebApplication", "@id": "https://fatbitchbook.com/armory.html#webapp", "name": "Sovereign GLP-1 Armory: PFH Motility Sizer, HOMA-IR Lab Prep & Prior Authorization Appeal Builder", "url": "https://fatbitchbook.com/armory.html", "applicationCategory": "HealthApplication", "operatingSystem": "All", "browserRequirements": "Requires JavaScript", "offers": { "@type": "Offer", "price": "0.00", "priceCurrency": "USD" }, "publisher": { "@id": "https://unlitpublishing.com/#organization" } }, { "@type": "FAQPage", "@id": "https://fatbitchbook.com/#faq", "mainEntity": [ { "@type": "Question", "name": "Why Willpower Fails: Hypothalamic POMC Neurons vs. The Engineered Bliss Point", "acceptedAnswer": { "@type": "Answer", "text": "The Willpower Myth is the disproven belief that chronic weight retention and persistent food thoughts stem from personal moral weakness. Clinical endocrinology demonstrates that hyperinsulinemia, leptin resistance, and corporate-engineered bliss-point foods override hypothalamic proopiomelanocortin (POMC) satiety neurons, creating a biological signaling deficit that GLP-1 receptor agonists correct." } }, { "@type": "Question", "name": "GLP-1 Constipation & Sulfur Burps: The 1:1 Water-to-Soluble-Fiber Motility Equation", "acceptedAnswer": { "@type": "Answer", "text": "GLP-1 medications intentionally slow gastric emptying to extend satiety, which reduces colonic water reabsorption time. Preventing GLP-1 constipation and sulfur burps requires a daily baseline of 0.5 ounces of water per pound of body weight plus 1 electrolyte serving, paired with 25 grams of soluble fiber and 1 extra ounce of water per gram of fiber." } }, { "@type": "Question", "name": "How to Appeal a Zepbound or Wegovy Prior Authorization Denial (AMA Resolution 420 Protocol)", "acceptedAnswer": { "@type": "Answer", "text": "An insurance Prior Authorization (PA) denial for Zepbound, Wegovy, Mounjaro, or Ozempic is an automated Pharmacy Benefit Manager (PBM) cost filter rather than a final clinical ruling. Successful appeals pair the exact denial code with AMA Resolution 420, a documented comorbidity and step-therapy history, objective HOMA-IR and ApoB labs, and Continuity of Care protections." } }, { "@type": "Question", "name": "The Medical CEO Lab Checklist: HOMA-IR, Fasting Insulin, ApoB & Firing Biased Providers", "acceptedAnswer": { "@type": "Answer", "text": "Acting as your own Medical CEO means treating your body as the enterprise and your healthcare providers as specialized technical consultants on your payroll. Before starting or titrating a GLP-1 medication, request a full metabolic baseline including Fasting Insulin, HOMA-IR, ApoB, Ferritin, Comprehensive Metabolic Panel (CMP), and a complete Thyroid panel (TSH, Free T3, Free T4)." } }, { "@type": "Question", "name": "Surviving Ozempic Anhedonia ('The Gray World'): The 4-Quadrant Joy List & Move Before Mood", "acceptedAnswer": { "@type": "Answer", "text": "Ozempic anhedonia (called 'The Gray World' in Fat Bitch) occurs because GLP-1 receptor agonists modulate mesolimbic dopamine pathways in the ventral tegmental area and nucleus accumbens. While this quiets compulsive food noise, it can temporarily flatten excitement for hobbies, music, and socializing, requiring structured non-food dopamine rebuilding via the 4-Quadrant Joy List." } }, { "@type": "Question", "name": "Tirzepatide & Oral Birth Control: The 4-Week Gastric Delay Rule & PCOS Ovulation", "acceptedAnswer": { "@type": "Answer", "text": "Tirzepatide (Mounjaro and Zepbound) measurably reduces the peak blood concentration and delays absorption of oral contraceptive pills due to slowed gastric emptying. FDA prescribing information directs patients on oral birth control to switch to a non-oral contraceptive or add a barrier backup method for 4 weeks after starting and for 4 weeks after every dose increase." } }, { "@type": "Question", "name": "The Bean Dip Pivot: 3 Boundary Scripts to Shut Down Holiday & Dinner-Table GLP-1 Shaming", "acceptedAnswer": { "@type": "Answer", "text": "The Bean Dip Pivot is a three-tier conversational boundary framework created by Cat Clark in Fat Bitch: Killing the Willpower Myth. It protects patient medical privacy during family gatherings and workplace meals by deflecting casual nosiness (Level 1), flipping the burden of justification (Level 2), or terminating intrusive questioning outright (Level 3)." } }, { "@type": "Question", "name": "Compounding Pharmacy Safety Screener: 503A vs. 503B, Base Molecules & Third-Party COAs", "acceptedAnswer": { "@type": "Answer", "text": "When evaluating compounded semaglutide or tirzepatide under a licensed prescriber's care, patients must verify five clinical safety criteria: state-licensed 503A patient-specific or FDA-registered 503B outsourcing facility status, PCAB/NABP accreditation, use of the exact base molecule rather than unapproved sodium or acetate salt forms, third-party Certificates of Analysis (COA), and transparent per-vial pricing." } }, { "@type": "Question", "name": "Protecting Lean Muscle on GLP-1s: The 100g Protein Floor & Nausea Cold-Texture Triage", "acceptedAnswer": { "@type": "Answer", "text": "Rapid weight loss without adequate dietary protein and mechanical load causes up to 25% to 39% of total weight lost to come from lean skeletal muscle mass, which lowers basal metabolic rate and increases frailty risk. The Holy Trinity Kitchen protocol establishes a daily minimum floor of 100 grams of protein paired with 2 to 3 weekly resistance training sessions." } }, { "@type": "Question", "name": "Skipping Before Pictures: The 25-Point NSV 5x5 Bingo Matrix & Monthly 8-Point Tape Log", "acceptedAnswer": { "@type": "Answer", "text": "Daily bathroom scale weights fluctuate by 2 to 6 pounds due to glycogen water binding, sodium intake, luteal-phase hormone shifts, and slower gastrointestinal transit on GLP-1s. Replacing daily scale policing and dehumanizing 'before' photos with a monthly 8-point sewing-tape log and the 25-Point Non-Scale Victory (NSV) 5x5 Bingo Matrix measures true functional health." } }, { "@type": "Question", "name": "Why Maintenance Is Not Failure: STEP-1 & SURMOUNT-4 Trial Data for GLP-1 Lifers", "acceptedAnswer": { "@type": "Answer", "text": "Both the STEP-1 semaglutide extension trial and the SURMOUNT-4 tirzepatide withdrawal trial proved that stopping GLP-1 therapy in patients with chronic metabolic dysfunction leads to regaining roughly 50% to 67% of lost weight and a return of cardiometabolic risk factors within 52 weeks. Long-term maintenance dosing treats a chronic endocrine condition just like thyroid hormone or antihypertensive therapy." } }, { "@type": "Question", "name": "20 Years After Skinny Bitch: Why 2005 Moral Blame Lost to 2026 Clinical Endocrinology", "acceptedAnswer": { "@type": "Answer", "text": "Published on the 20th anniversary of the 2005 diet book Skinny Bitch, Cat Clark's Fat Bitch: Killing the Willpower Myth replaces moralizing starvation mandates with peer-reviewed endocrinology. Where 2000s diet culture blamed women's character for hunger, 2026 metabolic science addresses the biological root causes: hyperinsulinemia, vagal-hypothalamic signaling, and ultra-processed food engineering." } } ] } ] }